(Press-News.org) Contact information: Brian Lin
brian.lin@ubc.ca
604-822-2234
University of British Columbia
UBC-VCH scientists use drug to repair rare birth defect
Success in mouse model is first instance of drug reversing a congenital deformity
University of British Columbia and Vancouver Coastal Health scientists
have developed a potential cure for a rare eye disease, showing for the first
time that a drug can repair a birth defect.
They formulated the drug Ataluren into eye drops, and found that it consistently restored normal vision in mice who had aniridia (ANN-uh-ridee-
uh), a condition that severely limits the vision of about 5,000 people in
North America. A small clinical trial with children and teens is expected to
begin next year in Vancouver, the U.S. and the U.K.
Aniridia is caused by the presence of a "nonsense mutation" – an extra "stop
sign" on the gene that interrupts production of a protein crucial for eye
development. Aniridia patients don't have an iris (the coloured ring around
the pupil), and suffer many other eye abnormalities.
Ataluren is believed to have the power to override the extra stop sign, thus
allowing the protein to be made. The UBC-VCH scientists initially thought
the drug would work only in utero – giving it to a pregnant mother to
prevent aniridia from ever arising in her fetus. But then they gave their
specially formulated Ataluren eye drops, which they call START, to two-week-old mice with aniridia, and found that it actually reversed the damage
they had been born with.
"We were amazed to see how malleable the eye is after birth," said Cheryl Gregory-Evans, associate professor of ophthalmology and visual sciences and a neurobiologist at the Vancouver Coastal Health Research Institute. "This holds promise for treating other eye conditions caused by nonsense mutations, including some types of macular degeneration. And if it reverses damage in the eye, it raises the possibility of a cure for other congenital disorders. The challenge is getting it to the right place at the right time."
A video about the study is available at http://youtu.be/L9Gx1bUxCUg.
BACKGROUND | A POTENTIAL CURE FOR ANIRIDIA
Bad vision at birth, worse vision later: Aniridia is apparent at birth because of the missing iris. Toddlers with aniridia need eyeglasses to see, sunglasses or darkened contact lenses to protect their eyes from overexposure to light, and cannot read small text. Their eyes are continually moving, making it difficult for them to focus, and have higher internal pressure (glaucoma), which damages the optic nerve as they get older. They are also prone to corneal damage in their teens and early adulthood. Eventually, most people with aniridia are considered legally blind, and must resort to Braille or expensive electronic aids to read.
The plasticity of the eye: The reversal of tissue damage in young mice,
published online today by the Journal of Clinical Investigation, fits with the
fact that mammals' eyes aren't fully formed at birth. Human babies don't
discern colours until they are six months old, and their depth perception
isn't fully developed until the age of five.
Nonsense suppressor: Ataluren, made by the New Jersey-based PTC Therapeutics, is thought to be a "nonsense suppressor" – it silences the extra "stop codon" on the gene and allows a complete protein to be assembled. The drug is currently being tested as a treatment for cystic fibrosis and Duchenne muscular dystrophy, which are also caused by nonsense
mutations.
A gritty solution: Gregory-Evans' first attempt at creating Ataluren eye
drops proved unsuccessful. The drug didn't dissolve, and thus irritated the
mice's eyes. So she turned to Kishor Wasan, a professor and associate dean
in the Faculty of Pharmaceutical Sciences, who ground the drug into a very fine powder and combined it with a solution that adhered better to the eye.
A multidisciplinary team: Gregory-Evans also collaborated with her
husband, Kevin Gregory-Evans, the Julia Levy BC Leadership Chair in
Macular Research and an ophthalmologist at the VCH Eye Care Centre, who treats B.C. patients with aniridia. He administered the vision tests for the mice used in the study.
Clinical trial: The forthcoming clinical trial, involving about 30 patients,
will be led by Gregory-Evans in Vancouver, and is being supported by the Vision for Tomorrow Foundation, a U.S.-based charity focused on aniridia
and albinism (an absence of pigmentation in skin, hair and eyes that results in poor vision). If START is proven to be safe and effective, children with aniridia would use the drops twice a day for the rest of their lives. The drug would probably not reverse the condition in adults because their eyes would already be damaged beyond repair.
INFORMATION:
Funding from a UBC alumna: Cheryl Gregory-Evans' position and this
research were funded by the Sharon Stewart Testamentary Trust. Stewart, of Victoria, was born with aniridia, and at the time of her graduation from
UBC in 1968, she only had five per cent of her vision. She died in 2008 and
donated over $6 million to UBC for aniridia research.
UBC-VCH scientists use drug to repair rare birth defect
Success in mouse model is first instance of drug reversing a congenital deformity
2013-12-20
ELSE PRESS RELEASES FROM THIS DATE:
Enlisting cells' protein recycling machinery to regulate plant products
2013-12-20
Enlisting cells' protein recycling machinery to regulate plant products
New molecular tools for controlling production of compounds important for flavors, human health, and biofuels
UPTON, NY--Scientists at the U.S. Department of Energy's Brookhaven ...
New mechanism that permits selective capture of microRNAs in nanovesicles that shuttle between cells
2013-12-20
New mechanism that permits selective capture of microRNAs in nanovesicles that shuttle between cells
The study presents the first description of a set of related nuceleotide sequences essential for the role of these small molecules in ...
More mentions in the FT linked to greater popularity of stocks
2013-12-20
More mentions in the FT linked to greater popularity of stocks
A 6-year study of the Financial Times has found that the more frequently a company is mentioned in the newspaper in the morning, the greater the volume of shares traded in that company during the ...
Efforts to curb climate change require greater emphasis on livestock
2013-12-20
Efforts to curb climate change require greater emphasis on livestock
CORVALLIS, Ore. – While climate change negotiators struggle to agree on ways to reduce carbon dioxide (CO2) emissions, they have paid inadequate attention to other greenhouse gases associated ...
Birth of black hole kills the radio star
2013-12-20
Birth of black hole kills the radio star
Research clears telescope, disproves long-held theory
Astronomers led by a Curtin University researcher have discovered a new population of exploding stars that "switch off" their radio transmissions before collapsing ...
An earthquake or a snow avalanche has its own shape
2013-12-20
An earthquake or a snow avalanche has its own shape
However, it is crucial what one observes – paper fracture or the avalanching of snow. The results were just published in the Nature Communications journal.
Avalanches of snow or earthquakes can be described in other ...
Smooth or grainy?
2013-12-20
Smooth or grainy?
A SISSA paper reviews research on the grain of space-time
Smooth" or grainy? Is space-time continuous or is it made up of very fine (10-35 metres on the "Planck scale") but discrete grains, if we look at it very ...
IRB develops ChroGPS, a new generation visual browser of the epigenome
2013-12-20
IRB develops ChroGPS, a new generation visual browser of the epigenome
This is a software application that provides easily interpretable maps from which to analyse and understand the immense volume of epigenetic and genetic ...
Birth control at the zoo
2013-12-20
Birth control at the zoo
Vets meet the elusive goal of hippo castration
Common hippopotami (Hippopotamus amphibius) are vulnerable to extinction in the wild, but reproduce extremely well under captive breeding conditions. Females ...
Breaking down cancer's defense mechanisms
2013-12-20
Breaking down cancer's defense mechanisms
A possible new method for treating pancreatic cancer which enables the body's immune system to attack and kill cancer cells has been developed by researchers.
The method uses a drug which breaks down the ...
LAST 30 PRESS RELEASES:
Toxic metals linked to impaired growth in infants in Guatemala
Being consistently physically active in adulthood linked to 30–40% lower risk of death
Nerve pain drug gabapentin linked to increased dementia, cognitive impairment risks
Children’s social care involvement common to nearly third of UK mums who died during perinatal period
‘Support, not judgement’: Study explores links between children’s social care involvement and maternal deaths
Ethnic minority and poorer children more likely to die in intensive care
Major progress in fertility preservation after treatment for cancer of the lymphatic system
Fewer complications after additional ultrasound in pregnant women who feel less fetal movement
Environmental impact of common pesticides seriously underestimated
The Milky Way could be teeming with more satellite galaxies than previously thought
New study reveals surprising reproductive secrets of a cricket-hunting parasitoid fly
Media Tip Sheet: Symposia at ESA2025
NSF CAREER Award will power UVA engineer’s research to improve drug purification
Tiny parasitoid flies show how early-life competition shapes adult success
New coating for glass promises energy-saving windows
Green spaces boost children’s cognitive skills and strengthen family well-being
Ancient trees dying faster than expected in Eastern Oregon
Study findings help hone precision of proven CVD risk tool
Most patients with advanced melanoma who received pre-surgical immunotherapy remain alive and disease free four years later
Introducing BioEmu: A generative AI Model that enables high-speed and accurate prediction of protein structural ensembles
Replacing mutated microglia with healthy microglia halts progression of genetic neurological disease in mice and humans
New research shows how tropical plants manage rival insect tenants by giving them separate ‘flats’
Condo-style living helps keep the peace inside these ant plants
Climate change action could dramatically limit rising UK heatwave deaths
Annual heat-related deaths projected to increase significantly due to climate and population change
Researchers discover new way cells protect themselves from damage
Rivers choose their path based on erosion — a discovery that could transform flood planning and restoration
New discovery reveals dopamine operates with surgical precision, not as a broad signal
New AI tool gives a helping hand to x ray diagnosis
New Leicester study reveals hidden heart risks in women with Type 2 Diabetes
[Press-News.org] UBC-VCH scientists use drug to repair rare birth defectSuccess in mouse model is first instance of drug reversing a congenital deformity